|
Market Closed -
Nasdaq
16:00:00 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 1.880 USD | +5.03% |
|
+16.77% | -74.46% |
| 08-31 | Karyopharm Therapeutics Submits Supplemental New Drug Application to the Fda for Xpovio Plus Ruxolitinib for Patients with Myelofibrosis | CI |
| 08-29 | Karyopharm Therapeutics Inc. - Special Call |
Stock exchange
Quotes 5-day view: Karyopharm Therapeutics Inc.
Delayed Quote Nasdaq
| 2026-09-14 | 2026-09-15 | 2026-09-16 | 2026-09-17 | 2026-09-18 | |
|---|---|---|---|---|---|
| Last | US$1.600 | US$1.540 | US$1.700 | US$1.790 | US$1.880 |
| Volume | 991,814 | 1,329,482 | 1,353,909 | 1,089,114 | 1,901,077 |
| Change | -0.62% | -3.75% | +10.39% | +5.29% | +5.03% |
| Opening | US$1.550 | US$1.590 | US$1.540 | US$1.747 | US$1.770 |
| High | US$1.620 | US$1.700 | US$1.720 | US$1.850 | US$1.885 |
| Low | US$1.550 | US$1.525 | US$1.540 | US$1.655 | US$1.670 |
Performance
| 1 day | +5.03% | ||
| 1 week | +16.77% | ||
| Current month | -8.74% | ||
| 1 month | -2.59% | ||
| 3 months | -79.16% | ||
| 6 months | -77.62% | ||
| Current year | -74.46% | ||
| 1 year | -67.19% | ||
| 3 years | -89.01% | ||
| 5 years | -97.94% | ||
| 10 years | -98.65% |
Volumes
marketsDaily volume
1,901,077
Estimated daily volume
1,901,077
Avg. Volume 20 sessions
1,516,497
Daily volume ratio
1.25
Avg. Volume 20 sessions USD
2,851,014.36
Record volume 1
22,398,319
Record volume 2
17,851,885
Record volume 3
6,737,667
Capital turnover ratio
0.07
Float rotation
0.07
Basic data
Market Cap (USD)
42,414,330
Net sales (USD)
146,067,000
Number of employees
228
Sales / Employee (USD)
640,645
Free-Float
95.33%
Free-Float capitalization (USD)
40,432,285
Average Daily Capital Traded
6.72%
Indicators
Moving average 5 days
1.702
Moving average 20 days
1.793
Moving average 50 days
3.952
Moving average 100 days
6.419
Price spread / (MMA5)
-9.47%
Price spread / (MMA20)
-4.63%
Price spread / (MMA50)
+110.23%
Price spread / (MMA100)
+241.41%
STIM
RSI 9 days
44.98
RSI 14 days
34.34
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.03% | +16.77% | -67.19% | -89.01% | 42.41M | |
| -0.58% | +0.43% | +31.09% | -4.81% | 78.35B | |
| -2.55% | +6.99% | +505.27% | +47.92% | 61.52B | |
| -1.11% | +5.08% | -11.47% | -33.91% | 59.78B | |
| +0.14% | -1.20% | -11.64% | +24.21% | 46.53B | |
| -0.24% | +1.22% | +2.26% | +151.03% | 45.5B | |
| -1.62% | -0.76% | +49.85% | -14.92% | 31.84B | |
| -1.81% | +3.16% | +45.71% | +110.57% | 25.4B | |
| +0.47% | +3.26% | -0.77% | +142.41% | 21.43B | |
| +0.27% | +1.96% | +62.19% | +102.81% | 15.77B | |
| Average | -0.20% | +3.66% | +60.53% | +43.63% | 38.62B | |
| Weighted average by Cap. | -0.92% | +2.35% | +93.50% | +40.26% |
Historical Quotes: Karyopharm Therapeutics Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
b2374c34.Z9qSZCBik3oHmkdcPPAqqX7-j0_TdY2yJaOOTU5F7jI.EezcKk4J2hZR03dld7Nj6geV_haSBNrFc5LMPykKvWAAlaE8UATJQje3Hg
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 1.880 | 455,818 | 1,499,895 |
| 15:59:58 | 1.870 | 100 | 1,044,077 |
| 15:59:58 | 1.870 | 120 | 1,043,977 |
| 15:59:58 | 1.870 | 580 | 1,043,857 |
| 15:59:58 | 1.870 | 120 | 1,043,277 |
| 15:59:58 | 1.880 | 100 | 1,043,157 |
| 15:59:58 | 1.880 | 400 | 1,043,057 |
| 15:59:58 | 1.880 | 100 | 1,042,657 |
| 15:59:55 | 1.870 | 200 | 1,042,557 |
| 15:59:55 | 1.870 | 200 | 1,042,357 |
Price Extremes
| 1 week | 1.52 |  | 1.88 |
| 1 month | 1.24 | | 2.14 |
| Current year | 1.24 | | 10.99 |
| 1 year | 1.24 | | 10.99 |
| 3 years | 1.24 | | 29.25 |
| 5 years | 1.24 | | 220.95 |
| 10 years | 1.24 | | 444.15 |
Monthly variations
Annual variations
| 2026 | -74.46% | ||
| 2025 | -27.45% | ||
| 2024 | -21.82% | ||
| 2023 | -74.56% | ||
| 2022 | -47.12% | ||
| 2021 | -58.46% | ||
| 2020 | -19.25% | ||
| 2019 | +104.59% | ||
| 2018 | -2.40% | ||
| 2017 | +2.13% | ||
| 2016 | -29.06% | ||
| 2015 | -64.60% | ||
| 2014 | +63.31% | ||
| 2013 | +42.80% |
- Stock Market
- Stocks
- KPTI Stock
- Quotes Karyopharm Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
